Investor profile for Genesys Capital: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.

VC fund profile · evidence-aware directory data

Genesys Capital stages, portfolio and investment profile

Genesys Capital is a Canadian life-sciences venture investor focused on early-stage biotechnology, pharmaceuticals and medical technology. It manages the Genesys University Seed Fund, which invests in pre-seed and seed companies emerging from Canadian academic and hospital research. Sources: https://www.genesyscapital.com/ and https://www.genesyscapital.com/news/genesys-capital-announces-second-close-of-genesys-university-seed-fund-welcoming-sunnybrook-and-uhn-as-hospital-partners

Keep track of Genesys Capital

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$250K–$3M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: October 19, 2026 View methodology

Investment stages

Leads: Not recorded

Participates: Pre-Seed, Seed

Sector focus

healthtech

Geography

Toronto, Ontario, Canada

Founded Not recorded

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

None yet

Linked startup profiles

Latest fund vehicle

Not recorded

Vehicle name, size, and vintage are not yet structured.

Recent tracked investment

Not recorded

No dated round explicitly links this fund.

Rounds they lead

Rounds they invest

Pre-Seed Seed

Last verified: 2026-10-19. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.